Director, Synthetic Molecules Analytical R&D

Company Description

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow @abbvie on X, Facebook, Instagram, You Tube, Linked In, and Tik Tok.

Description: The Analytical Research & Development team is seeking a talented, highly motivated candidate that is a recognized industry expert in areas of structural elucidation, impurity management including nitrosamine and mutagenic impurities, physical analytical characterization and methodology for enhanced stability modeling. The successful candidate will be responsible for leading a team in the design, development, and implementation of technology for the characterization of drug substance and drug products of synthetic molecules and peptides.

We are looking for diverse candidates with a strong scientific and leadership experience to join the Abb Vie Analytical R&D team and can offer exciting and rewarding career opportunities for these candidates. The ideal candidate will have CMC expertise in analytical development for both synthetic and biomolecule therapeutics. The candidate will be responsible for assisting with the development and execution of analytical methods to support CMC and will participate in phase‑appropriate characterization of material and products at all stages of the development process, as well as monitoring completion of tasks and projects.

This role will provide scientific leadership, strategic direction, and cross‑functional collaboration to ensure robust analytical control strategies aligned with regulatory expectations.

• Lead development and implementation of advanced analytical characterization for drug substance and drug product methods to support a range of modalities including small synthetic molecules and complex peptide development programs.
• Utilize cutting‑edge structure elucidation techniques (e.g., high‑resolution, tandem mass spectrometry, nuclear magnetic resonance) to characterize a wide range of modalities across Abb Vie’s pipeline.
• Lead cross‑functional teams and collaborate with multi‑disciplinary experts to develop strategies to enable the structure elucidation aspects of a project to advance programs through the development pipeline including impurity management to develop control strategies for mutagenic and nitrosamine impurities.
• Advance scientific expertise beyond ARD organization. Proactively advise and share knowledge and expert opinions with subordinates, peers, and senior management. Mentor and train colleagues and assess current and emerging business challenges enabling functional goal achievement.
• Ensure quality and effectiveness of key results of major project plans through sound design, early risk assessments, and implementation of fallback strategies.
• Source and identify emerging scientific trends in the field of molecular characterization of therapeutics from internal and external sources and assess relevance. Integrate trends into functional short‑term objectives. Advance cross discipline technology and direction within area of discipline.
• Apply imagination and innovation by creating, inventing, and implementing new or better approaches, alternatives and breakthrough ideas across disciplines.
• Make significant contributions to project team and deliver results in a team‑oriented setting and will work across scientific disciplines to drive programs through critical milestones.
• Generate new scientific proposals and lead those efforts. Anticipate and critically evaluate scientific or regulatory advances and respond with appropriate new strategies.
• Drive innovation and technical excellence for a multi‑functional organization.
• Drive scientific rigor, operational excellence, and consistent execution as a key contributor to overall CMC and portfolio strategy.

• PhD (with 12+ years’…